| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
2 companies
Orbimed Israel GP Ltd. last filed a Form 4 in January 2023, as 10% Owner at CMMB. The filings on record cover 2 companies.
At the last filing, the largest reported position was 2,241,274 shares of CMMB. The CMMB filings lean toward selling, a net 336,900 shares.
Orbimed Israel GP Ltd. has 6 Form 4 filings on record from May 2017 to January 2023, across 2 companies: 10% Owner at Chemomab Therapeutics (CMMB), 2021–2023; 10% Owner at Eledon Pharmaceuticals (ELDN), 2017–2020.
The 11 reported transactions were 5 open-market sales, 3 open-market purchases, 2 stock awards and 1 option or other derivative award.
Counted by filing, the open-market trades come to 1 purchase worth about $2.0M and 2 sales worth about $3.4M.
The only open-market purchase was 646,204 shares of ELDN at an average $3.10 on May 2, 2019, about $2.0M.
The largest open-market sale was 103,200 shares of ELDN at an average $21.60 on December 2, 2020, about $2.2M.
Shares as reported in the last Form 4 for each company; the most recent is from January 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | CMMB Chemomab Therapeutics Ltd. | 10% Owner | Sell | 336,900 | $3.58 | $1,207,759.08 | -13.1% | -49.0% | -81.8% | |
| Dec 2, 2020 | ELDN Eledon Pharmaceuticals, Inc. | 10% Owner | Sell | 103,200 | $21.60 | $2,229,120.00 | -58.4% | - | - | |
| May 2, 2019 | ELDN Eledon Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 646,204 | $3.10 | $2,003,232.40 | +25.5% | - | - |